No Cardiovascular Benefit Found for Rimonabant, Scripps Translational Science Institute Study  
12/30/2010 10:43:07 AM

MedPageToday -- Our Year in Review series highlights the major medical news stories of 2010. The failure of yet another diet drug, rimonabant, was one of the compelling topics that made headlines during the year and here, again, is the original article first published on Aug. 12, 2010. In a companion article, you'll find out what's happened since.